The advanced radiation therapy offers cancer patients quick, targeted treatments in one facility. The centers are the first ...

Highlights,Institutional firms have adjusted their holdings in Sensus Healthcare, reflecting ongoing market activity.,The ...

Chimerix’s lead clinical pipeline candidate is dordaviprone, a first-in-class small molecule treatment designed to selectively target the mitochondrial protease ClpP and dopamine receptor D2 (DRD2).

For select risk-enhanced individuals at intermediate risk of coronary artery disease (CAD), researchers found a way to ...

Fourth quarter 2024 net loss was approximately $4.9 million, or $0.20 per common share, a 45% improvement compared to approximately $8.9 million, or $0.42 per common share, in the three months ended ...

Maile Navarro’s 9-year-old son died. Now, the Redondo Beach resident and her young daughter are facing eviction.

With global cancer incidence rising and a strong clinical pipeline exploring combination therapies, the XPOVIO addressable market is expandin ...

Two Presentations Highlight Data Demonstrating Hypericin Photodynamic Therapy Potential with a Preliminary Comparison to Current Therapy ...